Results
1
Stocks where the price continues to rise after more than a year of consistent gains.
1 companies
Mendus
Market Cap: SEK 386.5m
A biopharmaceutical company, develops immunotherapies for the treatment of myeloid blood cancers.
IMMU
SEK 7.04
7D
32.3%
1Y
11.4%